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Abstract: 
 
While the composition of human milk has been studied extensively in the first year of lactation, 
there is a paucity of data regarding human milk composition beyond one year postpartum. 
Policies vary at milk banks around the world regarding how long lactating women are eligible to 
donate their milk. The primary purpose of this study is to describe longitudinal changes in human 
milk composition in the second year postpartum to support the development of evidence based 
guidelines regarding how long lactating women can donate human milk to a milk bank. Nineteen 
lactating women in North Carolina provided monthly milk samples from 11 months to 17 months 
postpartum (N = 131), and two non‐profit milk banks provided (N = 33) pooled, unpasteurized 
milk samples from 51 approved donors less than one year postpartum. There was a significant 
increase (P < 0.05) in the concentration of total protein, lactoferrin, lysozyme, Immunoglobulin 
A, oligosaccharides and sodium in longitudinal samples of mother's milk between 11 and 
17 months postpartum, while zinc and calcium concentrations declined, and no changes were 
observed in lactose, fat, iron and potassium. Human milk in the second year postpartum 
contained significantly higher concentrations of total protein, lactoferrin, lysozyme and 
Immunoglobulin A, than milk bank samples, and significantly lower concentrations of zinc, 
calcium, iron and oligosaccharides. Accepting milk bank donations beyond one year postpartum 
is a potential strategy for increasing the supply of donor milk, but may require mineral 
fortification. 
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Article: 
 
Introduction 
 
Human milk has long been considered the ‘gold standard’ of infant nutrition, supporting optimal 
growth and development in the neonate (Horta et al. 2007). While human milk composition has 
been studied extensively in the first year after parturition there is a paucity of data regarding milk 
composition beyond one year postpartum (Perrin et al. 2013). Weaknesses in the scientific 
literature include the use of cross‐sectional or semi‐longitudinal designs that may have masked 
changes because of inter‐individual variations; small sample sizes at later study time points; and 
limited or no information on major constituents in milk including bioactive proteins and human 
milk oligosaccharides (HMOS). Filling this research gap will create a greater understanding of 
the nutritional and immune contribution of human milk beyond infancy, and will also enable the 
creation of evidence‐based guidelines regarding milk bank donations. 
 
Human milk banking is supported by the World Health Organization (WHO 2008), the American 
Academy of Pediatrics (AAP 2012) and The United States Surgeon General (DHHS 2011) as a 
strategy for improving health outcomes and lowering health care costs among medically fragile 
infants who do not have access to their mother's milk (Ganapathy et al. 2012; Quigley & 
McGuire 2014). The duration that a lactating woman is eligible to donate her milk to a milk bank 
varies across the world, with some milk banks excluding donors as early as six months 
postpartum (Association of Italian Milk Banks, Milan, Italy), and other milk banks having no 
limits on the duration of donation (Milk Matters Milk Bank, Cape Town, South Africa). A 2013 
survey of milk banks in the Human Milk Banking Association of North America (HMBANA) 
network found that 8 of the 13 operating milk banks did not accept milk from donors beyond one 
year postpartum (Perrin et al. 2013). The use of donor milk is rising in United States' neonatal 
intensive care units (NICUs) (Perrine & Scanlon 2013), and so are donations to HMBANA milk 
banks (Updegrove 2013); however, currently less than 50% of NICUs in the United States use 
pasteurized donor milk (PDM) (Parker et al. 2013; Perrine & Scanlon 2013), suggesting that 
strategies may be needed to keep up with the growing demand. Allowing donation beyond one 
year postpartum for existing donors who continue to produce surplus milk is one potential 
strategy to increase supply. 
 
The primary purpose of this study is to describe longitudinal changes in human milk composition 
in the second year postpartum to support the development of evidence based guidelines 
regarding how long lactating women can donate human milk to a milk bank. The scope of this 
research includes: analysis of macronutrients (total protein, total fat and lactose); bioactive 
proteins that are typically abundant in human milk (lactoferrin, lysozyme and immunoglobulin 
A) (Mantis & Forbes 2010; Hettinga et al. 2011; Lönnerdal 2013); key minerals for the preterm 
neonate (calcium, zinc and iron) (Rao & Georgieff 2009; Abrams & Committee on 
Nutrition 2013; Griffin et al. 2013); sodium and potassium to monitor mammary gland 
involution (Neville et al. 1991) and HMOS, which have a role in immunity and the development 
of the gastrointestinal microbiome (Newburg 2009; Zivkovic et al. 2011; Bode 2012). We 
hypothesized that there would be no change in milk composition in the second year postpartum 
while daily feeding frequencies were maintained. A secondary purpose of this study is to 
compare the composition of human milk in the second year postpartum to raw milk samples 
accepted for donation in the HMBANA milk bank network. 
  
Key messages 
• Human milk contains increasing concentrations of total protein, lactoferrin, lysozyme, 
IgA, sodium and oligosaccharides, and decreasing concentrations of zinc and calcium, 
between 11 and 17 months postpartum. 
• A subject‐effect explains more of the variability in milk composition than a time‐effect 
between 11 and 17 months postpartum. 
• Human milk between 11 and 17 months postpartum provides equal or greater 
concentrations of macronutrients and key bioactive proteins compared with mature 
milk bank samples donated in the first year postpartum, but may require mineral 
fortification to meet the nutrient requirements of preterm infants. 
 
Subjects and methods 
 
Lactating women were recruited within a 1‐h driving radius of Raleigh, North Carolina from 
May 2013 to December 2013 using local parenting groups that communicated via Facebook. 
Women were eligible to participate if they had: given birth to a healthy, term infant who was 
between 9 and 11 months old at the time of recruitment; intended to breastfeed until their child 
was at least 18 months old and had access to a breast pump. Based on the results from previous 
studies on protein and calcium concentrations in milk, critical nutrients for the preterm neonate, 
the largest sample size computed to achieve 80% power with an alpha of 0.05, assuming a 20% 
change in these nutrients over the 7 month study period, was 16. Thirty‐three women were 
initially recruited to participate, assuming there might be a 50% dropout rate because of 
unplanned weaning. At the time of enrollment, participants signed an informed consent and were 
provided with verbal and written instruction for milk sample collection, as well as sterile 
collection containers and labels for collecting additional data about each sample. 
 
Sample collection 
 
Women were instructed to collect one milk sample per month, starting when their child was 
11 months old, by completely expressing the content of one breast during the first or second 
feeding of the morning. Expressed samples were transferred to a sterile collection container, 
labelled and stored in the subject's freezer until the researcher picked up the samples when the 
subject reached 18 months postpartum. Subjects were excluded from the study if they missed 
more than one collection in the 7‐month period. Feeding metrics collected with each sample 
included time of collection (FeedTime), time of prior feeding (PriorTime) and estimated number 
of feedings per day (FeedFreq). Month of lactation (Month) was assigned to each sample based 
on date of parturition, with the first sample collected before the infant turned one year old 
(Month = 11), representing milk that is eligible for donation to many milk banks. The average 
interval between sample collection was 31.5 ± 6.3 days (median = 31.0 days), suggesting that 
samples were consistently collected on a monthly cycle. The time interval between feedings 
(FeedInt) was computed using FeedTime and PriorTime. Volume was recorded for each sample, 
which represented the complete expression of the breast and provided an indication of overall 
milk making capabilities. Fourteen women dropped out of the study because of early weaning or 
missed sample collection, leaving 19 subjects who provided a total of 131 longitudinal samples 
of mother's own milk (MOM) for analysis. In addition, 33 unpasteurized, pooled human milk 
samples were obtained from Mother's Milk Bank (San Jose, CA) and The Northeast Mother's 
Milk Bank (Newton Upper Falls, MA), representing milk currently accepted by HMBANA milk 
banks (MB). MB samples had been pooled by multiple donors and/or multiple stages of lactation 
within a donor and represented milk from 51 women who delivered term infants, with an average 
stage of lactation of 4.8 ± 3.3 months (median = 4.0 months). 
 
Sample analysis 
 
Frozen samples were transported to our laboratory, thawed, aliquoted and stored at −80°C until 
further analysis. All samples were analysed in triplicate by the same researcher unless otherwise 
noted. The following nutrients were measured: total protein; total fat; lactose; lactoferrin; 
lysozyme; Immunoglobulin A (IgA); calcium; iron; zinc; potassium; sodium and total HMOS. 
 
Total protein was analysed using the bicinchoninic acid assay (BCA), which is based on the 
Biuret Reaction (PI23227; Fisher Scientific, Waltham, Massachusetts, USA) (Miller et al. 2013). 
Lysozyme was analysed based on changes in turbidity of a Micrococcus lysodeikticus (M3770; 
Sigma‐Aldrich, St. Louis, Missouri USA) bacterial suspension (Shugar 1952), and was adapted 
to a 96‐well plate format (Meng 2014). Lactoferrin and IgA were measured using an ELISA 
assay (EL2011‐1 and EI7001‐1, respectively; AssayPro, St. Charles, Missouri USA). The 
average intra‐assay coefficient of variation (CV) was 1.6%, 3.7%, 3.8% and 4.0% for total 
protein, lysozyme, lactoferrin and IgA, respectively. All protein assays were completed within 
one year of sample expression to ensure protein retention (Jensen 1995) except 19 samples for 
IgA and lactoferrin because of the need to repeat some assays (mean days between expression 
and assay of 224; minimum days of 23; maximum days of 433). 
 
Total fat was measured with a SMART Trac Rapid Moisture/Fat Analyzer (CEM Corporation, 
Mathews, NC) using microwave drying and nuclear magnetic resonance. This method was 
previously validated as reliable (Fogleman 2008); thus only 10% of the samples were analysed in 
duplicate. The average intra‐assay CV was 1.6%. 
 
Lactose and HMOS were analysed at Boston College (Chestnut Hill, MA) using graphitic carbon 
high‐performance liquid chromatography with tandem mass spectrometry, which has been 
described in detail elsewhere (Bao et al. 2013). Total HMOS reflect the sum of 2′‐fucosyllactose; 
3‐fucosyllactose; lacto‐N‐tetraose; lacto‐N‐fucopentaose I, II and III; lacto‐N‐difucohexaose I 
and II; lactodifucotetraose; monosialyllacto‐N‐neotetraose; monosialyllacto‐N‐tetraose; 3′‐
sialylactose; 6′‐sialylactose; disiayllacto‐N‐tetraose and sialyllacto‐N‐fucopentaose II and IV. 
Aliquots of milk samples were sent to Boston College on dry ice via overnight shipping. 
Duplicates of 10% of the samples were blinded to the researcher to evaluate the reliability of our 
methods, and the average CV for samples assayed in duplicate was 5.0% for lactose and 8.1% 
for total HMOS. 
 
Minerals were analysed using spectroscopy, and samples were prepared based on EPA Method 
3052 for microwave assisted acid digestion (EPA 1996), with modifications as follows: 10 mL of 
room temperature, vortexed milk was freeze‐dried in Teflon bottles using a Virtis 12XL 
Freezemobile (Virtis Company, Inc., Gardiner, New York, USA) to reduce contamination and 
eliminate the need for transferring samples; samples were heated on a hot plate instead of a 
microwave to reduce the chance of sample explosion and to increase the efficiency of processing 
a large number of samples; samples were totally digested using 10 mL of 15.8 N trace metal 
grade nitric acid (A509‐P212; Fisher Scientific), followed by 2 mL 30% hydrogen peroxide. 
Acid digestates were analysed using inductively coupled plasma optical emission spectroscopy 
(ICP‐OES), which was performed using a Perkin Elmer 8000 DV ICP‐OES (OPTIMA8000; 
Perkin Elmer, Waltham, Massachusetts, USA). Mineral analysis was conducted on single 
samples. Three of the subjects did not provide sufficient sample volume for mineral analysis; 
thus the mineral data represents longitudinal analysis on 16 subjects. 
 
Statistical analysis and ethical approval 
 
Summary statistics were calculated for target nutrients and feeding metrics based on Month of 
Lactation. A Random Coefficient Model was used to evaluate changes in MOM over time, which 
accounts for repeated measures from the same subject (Twisk 2004). Coefficients of 
determination (R2) were calculated to evaluate the goodness of fit of a bivariate regression model 
between target nutrients and Month of Lactation (a time‐effect) or Subject ID (a subject‐effect). 
A stepwise implementation within the Random Coefficient Model was used to evaluate whether 
additional independent variables explained changes in the target nutrients. Comparisons between 
MOM and MB samples were evaluated using a t‐test, and comparisons between MOM at 
different stages of lactation were evaluated using a t‐test with a Bonferroni's correction. All 
analysis was done using SAS software 9.3 (Cary, North Carolina). This study (protocol 3268) 
received ethical approval from the North Carolina State University Institutional Review Board. 
 
Results 
 
Temporal changes in mother's own milk 
 
Summary statistics by Month of Lactation are presented in Table 1. Total protein, lactoferrin, 
lysozyme, IgA, sodium and total HMOS showed a significant increase over time in MOM, while 
calcium and zinc decreased significantly over time when analysed with a Random Coefficient 
Model (Fig. 1). There was no evidence of longitudinal change in lactose, total fat, potassium and 
iron. The magnitude of the monthly change, as measured by the slope of the Random Coefficient 
Model divided by the average value at Month 11 (the control), was lowest for total protein 
(+1.9%) and total calcium (−1.6%), intermediate for sodium (+5.7%), zinc (−5.8%), IgA 
(+6.0%) and total HMOS (+5.0%), and largest for lactoferrin (+9.7%) and lysozyme (+10.2%). 
The Na : K ratio was significantly higher only at Month 16 (0.25 ± 0.20), compared with the 
control Month 11 (0.19 ± 0.06). One subject in the study consistently displayed the highest 
concentrations of total protein, lactoferrin, lysozyme and IgA over all months of the study 
period; therefore the Random Coefficient Model was rerun without the data from this subject and 
conclusions remained consistent. The number of daily feedings gradually decreased over the 
study period from 6.4 ± 1.5 at Month 11, to 4.3 ± 1.3 at Month 17 (Table 1). Similarly, the 
volume of milk extracted during the complete expression of the breast gradually declined, 
although a statistically significant difference was not observed until Month 17. 
 
Table 1. Composition of mother's own milk (MOM) by month of lactation  
Mother's own milk by month of lactation  
11 12 13 14 15 16 17 
# samples 19 19 19 19 18 18 18 
Volume (mL) 59 (28) 56 (33) 49 (23) 45 (24) 48 (27) 49 (28) 35*† (19) 
Feedings/day 6.4 (1.5) 5.8 (1.5) 5.2* (1.6) 5.0* (2.1) 4.6*† (1.4) 4.5*† (1.4) 4.3*† (1.3) 
Protein (g/dL) 1.6 (0.2) 1.6 (0.2) 1.7* (0.2) 1.8*† (0.2) 1.7*† (0.2) 1.7* (0.2) 1.8* (0.3) 
Lactose (g/dL) 5.7 (0.7) 6.0 (0.8) 5.6 (0.7) 5.9 (0.8) 5.7 (0.8) 5.5 (0.5) 5.6 (0.9) 
Fat (%) 4.0 (2.0) 3.9 (2.0) 4.6 (1.9) 5.4 (2.5) 4.3 (2.7) 3.9 (1.9) 4.6 (2.1) 
Lactoferrin (mg/dL) 180 (66) 200 (85) 210 (80) 230 (96) 250* (90) 270* (120) 280*† (110) 
Lysozyme (units/mL) 58 000 (31 000) 66 000 (35 000) 72 000 (40 000) 79 000 (46 000) 85 000* (43 000) 86 000* (44 000) 98 000*† (50 000) 
IgA (mg/dL) 21 (7.7) 23 (7.1) 25 (9.8) 28* (11) 27 (10) 28* (9.3) 29* (10) 
Total HMOS (mg/mL) 7.0 (2.1) 7.5 (1.9) 7.2 (2.6) 8.3 (3.4) 8.3 (2.3) 8.7 (2.9) 8.8* (3.8) 
Minerals 
       
# of Samples 16 16 16 16 16 16 14 
Total K (µg/mL) 370 (51) 380 (69) 370 (53) 380 (59) 380 (73) 360 (78) 370 (78) 
Total Na (µg/mL) 70 (19) 70 (24) 74 (34) 76 (34) 88* (23) 89* (25) 86 (35) 
Total Ca (µg/mL) 200 (29) 200 (25) 190 (29) 190 (27) 190 (25) 180 (36) 180 (30) 
Total Fe (ng/mL) 180 (87) 210 (110) 170 (130) 200 (100) 180 (110) 190 (91) 260 (140) 
Total Zn (ng/mL) 560 (330) 600 (360) 600 (390) 440 (250) 470 (320) 420 (350) 420 (310) 
Na : K ratio 0.19 (0.06) 0.19 (0.07) 0.20 (0.09) 0.20 (0.08) 0.25 (0.09) 0.25* (0.10) 0.23 (0.08) 
Data represents mean and (standard deviation) reported to two significant figures. 
* P < 0.05 for individual, independent comparisons to a control (month = 11) using a t‐test. 
† P < 0.007 for multiple comparisons to a control (month = 11) using a t‐test with a Bonferroni correction. 
 
 
Figure 1. Individual subject changes and an overall model predicting target nutrients that 
changed significantly over time (P < 0.05). 
 
There was a significant subject‐effect (P ≤ 0.01) for all nutrients in the Random Coefficient 
Model, regardless of whether there was a significant change over time. A bivariate analysis 
showed that the subject‐effect was greater than the time‐effect for all dependent variables, 
with R2 ranging from 0.314 to 0.850 for Subject ID and 0.006 to 0.121 for Month of Lactation 
(Table 2). 
 
  
Table 2. Contribution of subject ID (a subject‐effect) and month of lactation (a time‐effect) on 
predicting target nutrients using a bivariate regression analysis 
Dependent variable (Y) Coefficient of determination (R2) Ratio of subject effect : time effect  
Subject effect Time effect 
 
Protein 0.711 0.103 6.9 
Lactose 0.314 0.041 7.7 
Fat 0.526 0.054 9.7 
Lactoferrin 0.530 0.121 4.4 
Lysozyme 0.850 0.086 9.9 
IgA 0.755 0.080 9.4 
Total HMOS 0.574 0.065 8.8 
Total K 0.692 0.006 115.3 
Total Na 0.449 0.078 5.8 
Total Ca 0.543 0.056 9.7 
Total Fe 0.441 0.061 7.2 
Total Zn 0.823 0.058 14.2 
Na : K 0.432 0.064 6.8 
 
Other variables predicting changes in milk composition 
 
In a stepwise multiple regression analysis, Volume was a significant predictor variable for 8 of 
the 12 target nutrients (P ≤ 0.10) and exerted an inverse effect (as volume decreased, the nutrient 
concentration increased). The nutrients that Volume did not predict were lactose, calcium, zinc 
and total HMOS. The second most common predictor variable was the Na : K ratio, which was 
positively associated with changes in protein, lactoferrin, lysozyme, IgA and total HMOS, and 
inversely associated with changes in total zinc and iron. FeedTime was positively associated with 
IgA, potassium and calcium concentration (feedings at later times in the day had higher 
concentrations), and was negatively associated with iron concentration (feeding at later times in 
the day had lower concentrations). FeedInt exerted a significant negative effect on total fat (as 
the number of hours between feedings increased, the fat content decreased) and a positive impact 
on sodium (as the number of hours between feedings increased, the sodium increased). FeedFreq 
exerted a significant negative effect on lysozyme and total iron. Lactose concentrations were not 
predicted by any of the independent variables in the model. 
 
Second year mother's own milk vs. milk bank samples 
 
Analysis of MOM samples was limited to those greater than 30 mL when comparing to MB 
samples because Volume was a predictor of several nutrient changes in our multiple regression 
analysis and because women must be producing a minimum amount of expressed milk in order 
to donate to a milk bank. Of the 112 samples of MOM that were expressed in the second year 
postpartum, 79 of the samples (70.5%), which came from 16 of the subjects, were greater than 
30 mL. In a volume‐controlled analysis, MOM samples contained significantly higher 
concentrations of total protein, lactoferrin, lysozyme and IgA than MB samples (P ≤ 0.05), and 
significantly lower concentrations of calcium, iron, zinc and total HMOS (Table 3). 
 
  
Table 3. Comparison of mother's own milk > 30 mL to milk bank samples  
MOM > 30 mL (N = 79) MB (N = 33) P‐value 
Protein (g/dL)* 1.7 (0.2) 1.5 (0.2) <0.01 
Lactose (g/dL) 5.7 (0.8) 5.6 (0.7) 0.71 
Fat (%) 4.1 (2.1) 3.5 (1.7) 0.14 
Lactoferrin (mg/dL)* 210 (80) 140 (66) <0.01 
Lysozyme (units/mL)* 68 000 (34 000) 31 000 (24 000) <0.01 
IgA (mg/dL)* 23 (7.8) 17 (7.2) <0.01 
Total HMOS (mg/mL)* 8.2 (2.8) 9.3 (2.0) 0.05 
Total K (µg/mL) 370 (67) 390 (75) 0.15 
Total Na (µg/mL) 76 (26) 83 (31) 0.26 
Total Ca (µg/mL)* 190 (30) 220 (49) <0.01 
Total Fe (ng/mL)* 190 (110) 230 (64) 0.05 
Total Zn (ng/mL)* 540 (340) 1200 (700) <0.01 
Na K 0.21 (0.08) 0.21 (0.08) 0.97 
MOM, mother's own milk; MB, milk bank. 
Data represent means (standard deviations) reported to two significant figures. 
* Significant difference at P < 0.05 using a t‐test. 
 
Discussion 
 
Macronutrients 
 
The total protein concentration of human milk increased longitudinally in the second year 
postpartum, while there was no observed change in lactose concentration, which is consistent 
with other findings in the literature (Lauber & Reinhardt 1979; Garza et al. 1983; Dewey et 
al. 1984; Neville et al. 1991). The fat composition of human milk has traditionally been more 
difficult to assess because of within and between feed variations (Freed et al. 1986; Miller et 
al. 2013). Prior research on total fat composition in late lactation reported equivocal results, with 
some studies showing that total fat concentration increased (Underwood et al. 1970; Mandel et 
al. 2005), and other studies showing that fat content was stable (Lauber & Reinhardt 1979; 
Dewey et al. 1984). Our study, which controlled for month of lactation, collection time, 
collection volume and intervals between feeding, found that fat composition was not influenced 
by month of lactation, but increased as the milk volume in the breast decreased and as the 
interval between feedings decreased. Overall, these findings suggest that the macronutrient value 
of human milk in the second year postpartum is stable or increasing and is not inferior when 
compared with mature milk currently collected by HMBANA milk banks. 
 
Antimicrobial proteins 
 
We observed increases in three abundant antimicrobial proteins of human milk: lysozyme, 
lactoferrin and IgA. An increase in lysozyme concentration in the second year of lactation has 
been described by others using cross‐sectional or semi‐longitudinal study designs; however 
lactoferrin and IgA concentrations were reported as stable or declining in these studies 
(Goldman et al. 1983; Prentice et al. 1984; Hennart et al. 1991). Our research suggests that a 
strong subject‐effect explains the majority of differences in lactoferrin, lysozyme and IgA 
composition (R2 of 0.530, 0.850 and 0.755, respectively); therefore subject‐effects may have 
masked time‐related changes in cross‐sectional and semi‐longitudinal studies. Others who have 
studied lactoferrin, lysozyme and IgA in human milk longitudinally have also reported a strong 
subject‐effect (Lewis‐Jones, Lewis‐Jones et al. 1985). These antimicrobial proteins have been 
described as providing increased antioxidant capacity (Mehta & Petrova 2014), greater bone 
mineralization (Cornish et al. 2004), responsive and protective immunity (Breakey et al. 2015), 
and development of a beneficial gut microflora (Mastromarino et al. 2014). Concentrations of 
IgA and lactoferrin are highest in the first days of lactation and then rapidly decline (Goldman et 
al. 1982; Lewis‐Jones, Lewis‐Jones et al. 1985; Rai et al. 2014); therefore the higher 
concentrations we observed in the second year postpartum may better meet preterm infants' 
needs for these proteins than mature milk donated in the first year postpartum. 
 
Minerals 
 
In contrast to stable or increasing macronutrients and antimicrobial proteins, we observed a 
gradual longitudinal decline in the concentration of zinc and calcium, which is consistent with 
other findings in the literature (Vaughan et al. 1979; Dewey et al. 1984; Karra et al. 1986; 
Casey et al. 1989; Bates & Tsuchiya 1990; Laskey et al. 1990; Shehadeh et al. 2006). Zinc and 
calcium decreased less than 5% per month, suggesting that milk bank donations beyond one year 
postpartum may be slightly lower in some micronutrients that are important for the preterm 
infant. We validated this finding in our comparison of late‐lactation MOM samples to MB 
samples, where zinc, calcium and iron were significantly lower in MOM samples. 
 
Total HMOS 
 
This is the first study to report on total HMOS concentrations in the second year after parturition. 
Prior longitudinal research described decreasing concentrations of fucosylated HMOS in the first 
49 weeks of lactation (Chaturvedi et al. 2001). Our research showed a significant, gradual 
increase in total HMOS between 11 and 17 months postpartum in MOM; however HMOS 
composition in MOM was significantly lower than MB samples, and it was lower than values 
reported in the literature during early lactation (Chaturvedi et al. 2001; Bode 2012; Marx et 
al. 2014). 
 
Mammary gland changes 
 
The sodium–potassium ratio has been reported as a biomarker for measuring the function of 
mammary gland tight junctions, and thus the ability for some nutrients to flow into the mammary 
gland via paracellular pathways during the early lactation and weaning periods (Neville et 
al. 1991). Although minimal longitudinal changes in the mammary gland tight junction were 
observed using Na : K as a biomarker, it is possible that compositional changes were associated 
with decreased milk making capabilities in the mammary gland as evidenced by decreasing 
expression volumes and the significance of Volume as an inverse predictor variable for many 
analytes. 
 
Subject vs. time effect 
 
It is important to note that the subject‐effect explained more of the variation in all analytes within 
the longitudinal samples (R2 from 0.314 to 0.850) compared with the time‐effect (R2 from 0.006 
to 0.121). This suggests that the duration of lactation will have a smaller impact on the 
composition of PDM than the individual milk bank donors, and that pooling strategies are 
important for milk banks to reduce the variation in nutrients provided in donor milk. 
 
Limitations 
 
This study had several limitations. All subjects were recruited from the same geographic area, 
and no information was gathered on maternal diet patterns or illnesses, so there is the possibility 
that other factors may have contributed to the longitudinal changes in MOM that were observed. 
Historical research suggests that maternal diet patterns do not alter the target nutrients we 
analysed (Lönnerdal 1986); however, a recent small cross‐over study showed that elevated 
maternal fat intake resulted in an increase in total milk fat, although no changes in mammary 
gland gene expression were identified (Yahvah et al. 2015). The sample size in our study was 
relatively small; however, this was balanced by the fact that we collected repeated monthly 
measures on all subjects over seven months. We reported higher total protein levels than those 
often cited in the literature, which may be a result of analysis using the BCA method, which has 
been shown to overestimate total protein in human milk compared with other methods 
(Lönnerdal et al. 1987). Although this warrants further investigation, we achieved very low CVs 
on analyses performed in triplicate and feel confident in the trends that were identified, 
irrespective of absolute protein values. Our analysis only went through 17 months postpartum; 
therefore findings may not be generalizable to later postpartum periods. However, this research 
suggests that volume was a more consistent predictor of milk composition than month of 
lactation, suggesting that women who are still expressing milk volumes that are adequate for 
milk bank donation are likely to experience similar trends beyond 17 months postpartum to those 
observed in this study. 
 
Conclusions 
 
Our study found that human milk in the second year postpartum contains stable or increasing 
concentrations of macronutrients and bioactive factors, and small decreases in concentrations of 
zinc and calcium in women who continue to breastfeed or express milk at least three to four 
times per day. Accepting milk bank donations from lactating mothers beyond one year 
postpartum could increase the supply of PDM while also raising the concentration of total 
protein, lactoferrin, IgA and lysozyme in pooled donor milk; however mineral fortification might 
be considered. The European Society of Pediatric Gastroenterology, Hepatology and Nutrition 
(ESPGHAN) recommends that preterm infants receive higher concentrations of total protein, 
calcium, zinc and other micronutrients than are typically found in human milk (Agostoni et 
al. 2010), and the American Academy of Pediatrics recommends appropriate fortification of 
human milk for infants weighing less than 1500 g (AAP 2012). Fortifier products currently on 
the market contain high levels of many minerals including calcium and zinc, which were 
declining in second year milk samples (Abbott Nutrition 2015; Prolacta 2015). Future research 
should focus on mineral bioavailability and outcomes for preterm infants fed fortified MOM or 
PDM. Research into optimal milk bank pooling protocols is also warranted. 
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